CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 140,000 |
| 2023-08-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $43.53 | $435K | 623,666 |
| 2023-08-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 150,000 |
| 2023-08-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-15 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $43.77 | $438K | 623,666 |
| 2023-08-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 160,000 |
| 2023-08-14 | Daly James M Director | Sale | −10,000 | $43.74 | $437K | 20,503 |
| 2023-08-11 | Daly James M Director | Sale | −10,000 | $43.71 | $437K | 30,503 |
| 2023-07-27 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-07-27 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $43.79 | $438K | 623,666 |
| 2023-07-27 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 170,000 |
| 2023-07-26 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-07-26 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $42.69 | $427K | 623,666 |
| 2023-07-26 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 180,000 |
| 2023-07-25 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-07-25 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $42.80 | $428K | 623,666 |
| 2023-07-25 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 190,000 |
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $18.41 | $184K | 151,911 |
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $40.43 | $404K | 141,911 |
Page 37 of 48 · 944 trades